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Abstract
Background: Although breastfeeding is touted as providing many health benefits to infants, some aspects of this
relationship remain poorly understood.
Methods: The Environmental Determinants of Diabetes in the Young (TEDDY) is a prospective longitudinal study
that follows children from birth through childhood, and collects data on illness events, breastfeeding duration, and
time to introduction of formula or foods at 3 month intervals up until 4 years of age and at 6 months intervals thereafter.
Exclusive and non-exclusive breastfeeding is examined in relation to the 3-month odds of a respiratory or gastrointestinal
infection for 6861 children between the ages of 3–18 months, and 5666 children up to the age of 4 years. Analysis
was performed using logistic regression models with generalized estimating equation methodology. All models were
adjusted for potential confounding variables.
Results: At 3–6months of age, breastfeeding was found to be inversely associated with the odds of respiratory infections
with fever (OR = 0.82, 95% CI = 0.70–0.95), otitis media (OR = 0.76, 95% CI = 0.62–0.94), and infective gastroenteritis (OR =
0.55, 95% CI = 0.46–0.70), although the inverse association with respiratory illnesses was observed only for girls during the
winter months. Between 6 and 18 months of age, breastfeeding within any 3 month period continued to be
inversely associated with the odds of ear infection and infective gastroenteritis, and additionally with the odds of conjunctivitis,
and laryngitis and tracheitis, over the same 3 month period within this age range. However, breastfeeding in this
group was associated with increased reports of common cold. Duration of exclusive breastfeeding was inversely
associated with the odds of otitis media up to 48months of age (OR = 0.97, 95% CI = 0.95–0.99) after breastfeeding had
stopped.
Conclusions: This study demonstrates that breastfeeding can be protective against multiple respiratory and gastrointestinal
acute illnesses in some children up to at least 6 months of age, with duration of exclusive breastfeeding being
somewhat protective of otitis media even after breastfeeding has stopped.
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Background
The World Health Organization (WHO) recommends
that babies be exclusively breastfed until the age of 6
months, and continue to receive breast milk supplemen-
tary to solid foods for up to 2 years or beyond [1]. The
medical communities in the United States and in Europe
echo this recommendation with similar guidelines,
recommending exclusive breastfeeding for the first 4 to
6 months of a baby’s life [2–4]. One driving force behind
this policy is the mounting evidence of a multitude of
health benefits to the child as a result of breastfeeding.
The Environmental Determinants of Diabetes in the
Young (TEDDY) study is a large international observational
study following children from birth throughout childhood.
Among other information related to environmental expo-
sures, this study records initiation and cessation of breast-
feeding, timing of introduction to other foods, and all
illness events for each participant. As such, it is well-placed
to add to existing literature by exploring the relationship
between breastfeeding and rates of acute illnesses, both
during the time of breastfeeding and beyond.
The health benefits of breastfeeding can be thought of as
belonging to two categories – immediate benefits and
future benefits. Immediate benefits are those benefits that a
child receives from breastmilk during the time they are
breastfed. For example, during the time period when
breastfeeding is occurring, past studies have found a
correlation between breastfeeding and reduced frequency
of otitis media episodes [5–8], gastrointestinal infections
[8–11], lower respiratory infections [10–15], upper respira-
tory infections [11–14], urinary tract infections [16–18],
illness events in general [10, 19], and hospitalizations [19,
20]. However, for respiratory and gastrointestinal infec-
tions, in particular, there continues to be some uncertainty
about whether only exclusive breastfeeding is protective
[11, 14], any breastfeeding is protective [8, 10, 12, 13, 15],
or if breastfeeding is perhaps not protective at all [8].
Therefore, although these relationships have been studied,
the lack of consensus in previous studies’ results leaves a
gap in our understanding of the interplay between breast-
feeding and concurrent respiratory and gastrointestinal
illness in children. This paper provides new evidence that
weighs in on some of these contested findings.
Future benefits from breastfeeding, on the other hand,
are those that persist, or even manifest, after breastfeed-
ing has stopped. The majority of studies examining
future benefits of breastfeeding focus on various chronic
non-communicable diseases. In this vein, breastfeeding
as an infant has been shown to be associated with re-
duced risk of obesity, cardiovascular disease, diabetes,
cancer, and atopic disease (like asthma) later in life [21–
24]. Considerably less research has focused on the im-
pact of breastfeeding on acute illnesses in early child-
hood. Some studies that have explored this topic have
suggested a reduced rate of otitis media [25–29], respira-
tory infections [26–28, 30–32], throat infections [29],
sinus infections [29], and hospitalizations [20] among
children who were breastfed early in life. This paper will
add new insight into the poorly understood relationship
between breastfeeding as an infant and rates of acute
illness during early childhood. More specifically, it will
look at whether exclusive breastfeeding for longer dur-
ation has a larger impact on future rates of acute
respiratory and gastrointestinal illness during childhood
than exclusive breastfeeding for shorter duration.
Methods
The Environmental Determinants of Diabetes in the Young
(TEDDY) is a prospective cohort study funded by the
National Institutes of Health with the primary goal to iden-
tify environmental causes of type 1 diabetes (T1D). It
includes six clinical research centers - three in the US:
Colorado, Georgia/Florida, Washington; and three in
Europe: Finland, Germany, and Sweden. Children at each
location were screened at birth for high risk genes for T1D,
and those found to have these genetic markers were invited
to be followed by the TEDDY Study. Detailed study design
and methods have been previously published [33, 34].
Written informed consents were obtained for all study
participants from a parent or primary caretaker for genetic
screening and, separately, for participation in prospective
follow-up. The study was approved by local Institutional
Review Boards and is monitored by the External Evaluation
Committee formed by the National Institutes of Health.
Study participants come to the clinic every 3 months
until the age of 4 years, and then every 6 months beyond
this. Because the interval of reporting changes at the age
of 4 years, for the purpose of this study, only follow-up
data up to the age of 4 years will be included in the ana-
lysis. Between visits, parents record a wide variety of en-
vironmental exposures – including detailed information
on breastfeeding, diet, and illness events – in a TEDDY
book, or log, which is then reviewed by a clinician at
each visit. The clinician uses this log, as well as parental
input, to complete a questionnaire, which compiles the
information from the TEDDY book in an organized
fashion, and which is the source of the data used in this
analysis. Therefore, the age at which the mother stopped
exclusively breastfeeding (or introduced other foods or
formulas), and the age at which the mother stopped
breastfeeding at all were gleaned from these clinic visit
questionnaires. Likewise, the TEDDY book (and there-
fore the visit questionnaires) records all reported infec-
tions experienced by the child since the last visit. The
data collector reviews the reported illness symptoms,
asks for clarifying information when appropriate, and
assigns an ICD code or codes to each infectious episode,
which are then entered into the study database. These
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codes are extracted from the database for data analysis.
TEDDY has developed a method for reporting and clas-
sifying acute infectious diseases using these self-reported
data, which is described in a previous publication [35].
The longitudinal follow-up of the children was broken
up into three-month age intervals, according to time be-
tween visits, for each family. The exact intervals were
from (but not including) the day of the last visit when
the TEDDY book questionnaire was completed, to (and
including) the day of the current visit. If the family did
not fill in the TEDDY book for a scheduled visit, the
intervals were maintained in a 3 month time series by
using the expected due date for the visit. All analysis was
made on a 3 month level scale to reduce the influence of
possible recall bias, or systematic error resulting from
differences in accuracy of reporting, as to when an infec-
tion occurred within the last 3 months.
Of the 8676 children enrolled in TEDDY, 6861 were
older than 18months of age at their last clinic visit, had
not developed islet autoantibodies or T1D at the time of
questionnaire submission, and had no conflicting reported
breastfeeding data (for example, where two different ques-
tionnaires listed two different dates of cessation of breast-
feeding for the same participant) (Fig. 1). The participants
for this analysis were born between September 1st 2004
and February 28th 2010 and were followed up to 48
months of age. We analyzed the data as of August 31st
2016, 2 years after the last 48month visit window for the
study ended.
Data collected after a study participant tested positive
for islet autoantibodies or developed T1D were excluded
from this analysis due to concern that parents of this
group may systematically report illness events differently,
thus introducing a source of recall bias to the analysis.
The odds of infections in a three-month period among
children who were breastfed at the last visit (i.e. who were
breastfeeding at the start of the three-month interval)
compared to children who were not breast fed at the last
visit (or not breast fed at the start of the three-month
interval) were calculated from coefficients of marginal
logistic regression models. To account for the correlation
of infections reported by the same family at multiple visits,
the logistic models were estimated using Generalized Esti-
mating Equations (GEE) with robust standard errors. The
mean relationship between breastfeeding and its associ-
ation with the presence of an infection was of most
importance, and, therefore, we compared the coefficients
from models assuming an independent, exchangeable and
autoregressive covariance structure to make sure careful
modeling of the covariance structure was not necessary.
Final models used an exchangeable covariance structure,
and were adjusted for gender, age of child, age of mother
at birth, maternal education, single child, number of
rooms in household, parental working and smoking status
when child was 9 months of age, country, if the child was
a first degree relative of a type 1 diabetic individual,
whether daycare or social group had started at the last
visit, and season of the year when the 3 month history of
infections was reported.
Children who were a) exclusively breastfed (i.e. had
not yet been introduced to formula or foods other than
breast milk), b) breastfed but not exclusively (i.e. still
received breast milk, but had also been introduced to
formula and/or other foods) and c) no longer breastfed
at 3 months of age were first examined in relation to
respiratory and gastrointestinal infections between 3 and
6month of age. Overall significance of association with
each infection was examined by a Wald test. Next, breast-
feeding after 6months, which consisted mostly of children
who were non-exclusively breastfed, was examined with
relationship to odds of infection at 3months intervals up
to 18months of age when 93% of children had stopped
breastfeeding. Lastly, the relationship between the total
duration of exclusive breastfeeding and the prevalence
of infections after 12 months of age was examined, ad-
justed for age of the child and duration of non-exclusive
breastfeeding. Of particular interest were associations of
breastfeeding with respiratory and gastrointestinal infec-
tious episodes overall, as well as common subsets of
respiratory and gastrointestinal infections, including:
respiratory infections with fever, common cold, laryngi-
tis and tracheitis, influenza, enterovirus, tonsillitis or
Streptococcal pharyngitis, infections of the middle ear,
bronchitis and lower respiratory infections, conjunctivitis,
gastrointestinal infections with fever, infective gastroenter-
itis, and gastrointestinal symptoms. Other less common
illness categories were excluded. No adjustment for mul-
tiple comparisons was made. All P-values were two sided.
SAS 9.3 (SAS Institute Inc., Cary, NC) was used for the
statistical analyses and GraphPad PRISM 5.03 (GraphPad
Software Inc., San Diego, CA) for graphs. The STROBE
(Strengthening the Reporting of Observational studies in
Epidemiology) guidelines were followed in the reporting
of this research.
Results
The cohort included 6861 children who were followed for
longer than 18months, and up to a maximum of 48
months of age, and who were not islet autoantibody posi-
tive or diabetic at the time of data collection. In all there
were 21,330 person years of follow-up of reported infec-
tions with a median recall period of 3months (Fig. 1). The
study population is described in more detail in Table 1.
Are exclusive and non-exclusive breastfeeding associated
with presence of infection between age 3 and 6months?
At 6months of age, 6720/6861 (98.0%) of the children
had a parent report of experiencing at least one infection
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since enrollment at 3 months of age. Of these children
1628 (24.3%) were still being breastfed exclusively at en-
rollment, 3396 (50.7%) were still breastfed but not exclu-
sively (ie, the breast milk was supplemented with other
types of food or formula prior to enrollment), and 1669
(24.9%) were not being breastfed at time of enrollment.
The odds of a gastrointestinal infectious episode (p =
0.0001) were significantly reduced among children who
were breastfed (both exclusively and non-exclusively)
compared to children who were not breastfed (Fig. 2).
This inverse association was strongest on the odds of
gastrointestinal infectious episodes, when the episode in-
cluded an ICD10 report for infective gastroenteritis (as
opposed to just reporting non-specific gastroenteritis
symptoms such as nausea or vomiting) (non-exclusive vs
no breastfeeding; OR 0.60, 95% CI = 0.46–0.77; exclusive
vs no breastfeeding, OR = 0.45, 95% CI = 0.32–0.62). An
inverse association was also observed on respiratory in-
fectious episodes with a reported fever (non-exclusive vs
no breastfeeding; OR 0.86, 95% CI = 0.73–1.00; exclusive
vs no breastfeeding, OR = 0.72, 95% CI = 0.60–0.87) or
with a reported otitis media (non-exclusive vs no breast-
feeding; OR 0.81, 95% CI = 0.66–1.00; exclusive vs no
breastfeeding, OR = 0.64, 95% CI = 0.49–0.84) for both
groups (Fig. 2).
Is breastfeeding associated with presence of infection
between 6 and 18months of age?
Between the age of 6 and 18months, breastfeeding within
any 3 month period remained inversely associated with
Fig. 1 Selection of study population
Frank et al. BMC Pediatrics          (2019) 19:339 Page 4 of 12
the odds of otitis media (OR = 0.89, 95% CI = 0.82–0.97,
p = 0.008) and infective gastroenteritis (OR = 0.89, 95%
CI = 0.81–0.98, p = 0.01) over the same 3 month period
within this age range, but not of febrile respiratory and
gastrointestinal episodes in general (Table 2). In
addition, for children aged 6 to 18 months, breastfeeding
within any 3 month period was more inversely associ-
ated with the odds of conjunctivitis (OR = 0.86, 95%
CI = 0.74–1.0, p = 0.04) and laryngitis and tracheitis
(OR = 0.79, 95% CI = 0.63–0.97, p = 0.03) over the same
3 month period, compared to children aged 3 to 6
months, for whom no association was found (conjunc-
tivitis: OR = 1.17, 95% CI = 0.87–1.57, p = 0.29; laryngitis
and tracheitis: OR = 0.88, 95% CI = 0.52–1.49, p = 0.64)
(Table 2). Of note, when analyzed in smaller age incre-
ments (i.e. 6–12 months and 12–18 months), the above
trends remained the same (data not shown).
Breastfeeding within any 3 month period among chil-
dren aged 6 to 18months was associated with increased
odds of reported respiratory infectious episodes over the
same 3 month period within this age range (OR = 1.17,
95% CI = 1.09–1.26, p < 0.0001), particularly when the
episodes included a report of a common cold (OR =
1.25, 95% CI = 1.17–1.34, p < 0.0001) (Table 2).
Table 1 Description of study population (n = 6861)
Characteristic N (%)
Sex
Male 3504 (51.1)
Female 3357 (48.9)
Country
US-Colorado 1110 (16.2)
US-Georgia/Florida 653 (9.5)
US-Washington 1001 (14.6)
US-satellite sites 7 (0.1)
Germany 436 (6.4)
Finland 1557 (22.7)
Sweden 2097 (30.6)
Maternal Education
Basic Primary 1252 (18.7)
High School 1648 (24.6)
Beyond High School 3800 (56.7)
missing 161
Age of Mother at Birth
< 25 years 763 (11.1)
25–29 years 1997 (29.1)
30–34 years 2470 (36.0)
> 35 years 1631 (23.8)
Number of room in house residence
≤ 3 rooms 780 (11.7)
3–6 rooms 3641 (54.4)
> 6 rooms 2269 (33.9)
missing 171
Maternal Working Status at 9 months
Working 2385 (35.7)
Not Working 4289 (64.3)
missing 187
Maternal Smoking Status at 9 months
Smoker 618 (9.2)
Non-smoker 6092 (90.8)
missing 151
Age Child Started Daycare or joined social group
< 3months 2065 (30.7)
3–6 months 1647 (24.5)
6–12 months 1266 (18.8)
12–18months 920 (13.7)
≥ 18months or no 839 (12.5)
missing 124
Child Birthweight
SGA (< 2500 g) 221 (3.3)
AGA (2500–4000 g) 5369 (90.2)
Table 1 Description of study population (n = 6861) (Continued)
Characteristic N (%)
LGA (> 4000 g) 1102 (16.5)
missing 169
First Degree Relative with Type 1 Diabetes
Yes 798 (11.6)
No 6063 (88.4)
Single child in house at 9 months of age
Yes 2806 (41.9)
No 3896 (58.1)
missing 159
Breastfeeding Duration
< 3months 1724 (25.2)
3–6 months 834 (12.2)
6–9 months 1420 (20.8)
9–12 months 1299 (19.0)
12–15months 726 (10.6)
15–18months 335 (4.9)
> 18 months 495 (7.3)
missing 28
Exclusive Breastfeeding Duration
< 3months 5201 (75.8)
3–6 months 1371 (20.0)
6–9 months 287 (4.2)
9–12 months 2 (0.0)
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Fig. 2 Odds of infection among breastfed children age 3–6 months compared to non-breastfed children
Table 2 Breastfeeding in relation to the age-specific odds of an infection within a 3-month period
Infection/symptoms Age period
3 to 6 months
Age period
> 6 to 18 months
Breastfed
Yes vs. No
a-OR (95% CI)
Breastfed
Yes vs. No
a-OR (95% CI)
p-value
Respiratory 1.04 (0.91–1.19) 0.61 1.17 (1.09–1.26) < 0.0001
With fever 0.82 (0.70–0.95) 0.008 1.08 (1.01–1.15) 0.04
Common cold 1.10 (0.97–1.26) 0.15 1.25 (1.17–1.34) < 0.0001
Laryngitis and tracheitis 0.88 (0.52–1.49) 0.64 0.79 (0.63–0.97) 0.03
Influenza – 0.85 (0.63–1.15) 0.29
Enterovirus – 0.97 (0.71–1.33) 0.87
Tonsillitis or Streptococcal pharyngitis – 1.02 (0.76–1.37) 0.91
Infection of the middle ear 0.76 (0.62–0.94) 0.01 0.89 (0.82–0.97) 0.008
Bronchitis and lower resp. infection 0.87 (0.71–1.06) 0.17 1.00 (0.91–1.10) 0.93
Conjunctivitis 1.17 (0.87–1.57) 0.29 0.86 (0.74–1.00) 0.04
Gastrointestinal 0.66 (0.53–0.83) 0.0003 0.96 (0.88–1.05) 0.96
With fever 0.58 (0.41–0.82) 0.0002 0.91 (0.79–1.03) 0.14
Infective gastroenteritis 0.55 (0.46–0.70) < 0.0001 0.89 (0.81–0.98) 0.01
Gastroenteritis symptoms 0.69 (0.51–0.93) 0.02 1.05 (0.94–1.16) 0.40
a-ORs = odds ratio are adjusted (a) for gender, age of child, age of mother at birth, maternal education, single child, number of rooms in household, parental
working and smoking status when child was 9 months of age, country, if the child was a first degree relative of a type 1 diabetic individual, whether daycare or
social group had started at the last visit, and season of the year at the start of the interval (i.e. last visit). Bold face type indicates statistical significance with a
p-value < 0.05
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Does length of exclusive breastfeeding alter the change
in odds of an infection after breastfeeding has stopped?
By 9months of age, all but two children had stopped be-
ing exclusively breastfed. At the age of 12 months, none
of the children were exclusively breastfed. When exam-
ining infections after 12 months of age, each additional
month of exclusive breastfeeding was associated with
slightly reduced odds of an otitis media episode (/month
increase duration of exclusive breastfeeding, OR = 0.97,
95% CI = 0.95–0.99, p = 0.004) in children for whom
breastfeeding had been stopped (Table 3). No other
significant association was found between duration of
exclusive breastfeeding during the first 12 months and
either gastrointestinal or respiratory infectious episodes
after 12 months of age (Table 3).
Are the associations between breastfeeding and reported
infections modified by sex of child, place of residence or
season?
Breastfeeding or length of breastfeeding and the association
with infections after 6months of age were not modified by
gender, place of residence or season at last 3-month visit.
The inverse association between breastfeeding at 3months
of age and respiratory infectious episodes with a reported
fever (Table 4) (interaction, gender, p = 0.01; season age 3
months, p = 0.02), or with a reported otitis media (Table 5)
(interaction, gender, p = 0.02, season at 3months, p = 0.02)
between 3 and 6months of age were both modified by sex
of child and season when the child was 3months of age.
Among girls, breastfeeding was associated with a lower
odds of both respiratory infectious episodes with a re-
ported fever (yes breastfeeding vs no breastfeeding; OR
0.66, 95% CI = 0.54–0.83) and a reported otitis media (yes
breastfeeding vs. no vs no; OR 0.55, 95% CI = 0.41–0.74).
No associations with these infections were seen among
boys (respiratory infectious episodes with a reported fever;
yes breastfeeding vs no breastfeeding; OR 0.98, 95% CI =
0.80–1.21; a reported otitis media, yes breastfeeding vs. no;
OR 1.02, 95% CI = 0.77–1.35). Similarly, when the child
was 3months of age, only if the season was December to
February was breastfeeding associated with decreased inci-
dence of a respiratory infectious episodes with a reported
fever (yes breastfeeding vs no breastfeeding; OR 0.56, 95%
CI = 0.41–0.76) or with otitis media (yes breastfeeding vs
no breastfeeding; OR 0.45, 95% CI = 0.29–0.70). At other
3-month seasons, no associations were observed (ORs >
0.77). Site or continent of residence did not modify the
associations.
Discussion
To better understand the results of this study, it is useful
to place them in the broader context of previous research.
Table 3 Duration of exclusive breastfeeding on the odds of a respiratory or gastrointestinal infection in any three-month interval
after 12 months of age among children no longer being breastfed and followed in the study until at least 48 months of age (n =
5666)
Length of exclusive
Breastfeeding on odds of infection in a 3 month period
/ months
a-OR (95% CI)
p-value
Respiratory
Overall 1.009 (0.994–1.023) 0.25
With fever 1.004 (0.990–1.017) 0.61
Common cold 1.013 (0.999–1.028) 0.07
Laryngitis and tracheitis 0.985 (0.939–1.033) 0.54
Influenza 1.027 (0.983–1.073) 0.23
Enterovirus 1.002 (0.959–1.048) 0.92
Tonsillitis or Streptococcal pharyngitis 0.996 (0.956–1.035) 0.84
Infection of the middle ear 0.971 (0.952–0.991) 0.004
Bronchitis and lower resp. infection 0.993 (0.974–1.012) 0.48
Conjunctivitis 0.988 (0.964–1.012) 0.33
Gastrointestinal
Overall 1.010 (0.996–1.024) 0.16
With fever 0.998 (0.977–1.018) 0.81
Infective gastroenteritis 1.014 (0.997–1.031) 0.11
Gastroenteritis symptoms 1.010 (0.994–1.026) 0.22
Length of exclusive breastfeeding is included in same multivariate outcome on infection a-ORs = odds ratios adjusted (a) for factors in Table 1, and age of the
child. Bold face type indicates statistical significance with a p-value < 0.05
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One of the more widely published findings on the rela-
tionship between breastfeeding and concurrent illness is
the decreased incidence of otitis media in children who
breastfeed when compared to children who do not. The
findings of this study – that both exclusive and non-exclu-
sive breastfeeding are protective against acute otitis media
– therefore echo the findings of multiple other studies [5,
6, 8]. This study further clarifies these relationships by in-
dicating that the protective effects of breastfeeding remain
at work at least through the age of 18months for children
who continue to receive breastmilk. This is not an unpre-
cedented discovery as, according to a meta-analysis pub-
lished in 2015, cumulative evidence supports that
breastfeeding protects against otitis media until the age of
2 years [36].
Our findings regarding the lower rates of infective
gastroenteritis in breastfed children also help to clarify
relationships shown in other studies. For example,
several studies found exclusive breastfeeding for the first
6 months of life to be protective against gastrointestinal
Table 4 Breastfeeding at 3 months of age on Febrile Respiratory Infections between 3 and 6 months of age
Factor N % Reporting febrile respiratory infection by whether or not
child still breastfeeding at 3 months of age
Breastfeeding on odds of Febrile respiratory infection
between 3 and 6 months of age
No Yes a-OR 95% CI Interaction
p-value
Gender
Female N = 3276 24.9% 20.4% 0.66 0.54–0.83
Male N = 3418 23.3% 23.9% 0.98 0.80–1.21 0.01
Continent
US N = 2665 19.1% 15.6% 0.80 0.62–1.03
Europe N = 4029 28.9% 26.0% 0.82 0.68–0.99 0.51
Season age 3mo
Dec – Feb N = 1595 26.9 19.5 0.56 0.41–0.76
Mar – May N = 1275 29.9 27.0 0.85 0.64–1.12
Jun – Aug N = 1672 24.0 25.6 1.05 0.78–1.43
Sept - Nov N = 1730 16.5 16.5 0.83 0.59–1.16 0.02
a-ORs = odds ratio are adjusted (a) for age of mother at birth, maternal education, single child, number of rooms in household, parental working and smoking
status when child was 9 months of age, if the child was a first degree relative of a type 1 diabetic individual, whether daycare or social group had started at the
last visit and other variable not being examined for interaction (gender, continent or season at 3 months of age). Bold face type indicates statistical significance
with a p-value < 0.05
Table 5 Breastfeeding at 3 months of age on Infection of Middle Ear between 3 and 6 months of age
Factor N % Reporting infection of middle ear by whether or not child
still breastfeeding at 3 months of age
Breastfeeding on odds of infection of middle between 3
and 6months of age
No Yes a-OR 95%CI Interaction
p-value
Gender
Female N = 3276 14.1% 9.0% 0.55 0.41–0.74
Male N = 3418 12.2% 11.4% 1.02 0.77–1.35 0.02
Continent
US N = 2665 17.4% 13.6% 0.76 0.58–0.99
Europe N = 4029 9.1% 8.4% 0.77 0.57–1.05 0.68
Season age 3mo
Dec – Feb N = 1595 14.2% 7.8% 0.45 0.29–0.70
Mar – May N = 1275 15.6% 12.1% 0.77 0.53–1.12
Jun – Aug N = 1672 12.8% 13.1% 1.00 0.67–1.48
Sept - Nov N = 1730 10.4% 8.1% 0.85 Few infections 0.02
a-ORs = odds ratio are adjusted (a) for age of mother at birth, maternal education, single child, number of rooms in household, parental working and smoking
status when child was 9 months of age, if the child was a first degree relative of a type 1 diabetic individual, whether daycare or social group had started at the
last visit and other variable not being examined for interaction (gender, continent or season at 3 months of age). Bold face type indicates statistical significance
with a p-value < 0.05
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infections during that time, compared to children who
were formula fed or who were breastfed for a shorter
period of time [9–11]. A study conducted by Dewey and
colleagues, alternatively, found that children for whom
breast milk was the primary source of milk up to or
beyond the age of 12 months had fewer gastrointestinal
infections in the first year of life than children who were
never breastfed [8]. Our study helpfully further eluci-
dates the relationship between breastfeeding and concur-
rent gastrointestinal illness, demonstrating that both
exclusive and non-exclusive breastfeeding may offer pro-
tection against gastrointestinal illness in the first 6
months of life. This study also followed these trends
through the age of 18 months, showing that the protect-
ive properties of breastfeeding continue through this age
range in children who continue to receive breastmilk,
but that the protection is somewhat less in the older age
group.
Additionally, this study found exclusive and non-ex-
clusive breastfeeding between ages 3–6 months to be
protective against respiratory infections with fever. This
category of illness could potentially be viewed as repre-
senting the most severe respiratory infections, leading us
to consider the possibility that, although this study fails
to show a decrease in total respiratory infectious epi-
sodes among breastfed infants aged 3–6 months, their
respiratory infections may be less severe than those of
non-breastfed infants. An unexpected finding of this
study was that, although breastfeeding over the age of 6
months was found to be protective against concurrent
conjunctivitis or tracheitis/laryngitis, respiratory infec-
tions in general - and especially common colds (which
was the largest category of respiratory infection) - were
more frequently reported in children over 6 months of
age who were breastfed than in children who were not
breastfed at those ages.
This last finding is not common in the published litera-
ture. A study conducted by Cushing et al. found, like we
did, that the risk of upper respiratory infection increased
with breastfeeding, but the association was not statistically
significant [15]. Dewey et al. found no association between
breastfeeding and the frequency of respiratory infections
(which they claim were nearly all upper respiratory infec-
tions) in the first or second year of life, when comparing
children who breastfed for 12 months or more to children
who never breastfed [8]. And multiple studies actually
found breastfeeding to be associated with lower risk of
upper respiratory tract infections [11, 12], or acute re-
spiratory infections in general [13, 14].
We hypothesize that the apparent positive association
between breastfeeding and the common cold may not
represent a true causal relationship. This leads us to
consider one potential limitation of this study – namely
that this study relies upon parental report for its data.
Although data is collected on a regular basis from parents,
parents may differ in the accuracy of their reporting, or
their consideration of what constitutes a true illness.
This variability may be magnified for so-called “minor”
illnesses, like the common cold. Therefore, the per-
ceived effect of breastfeeding on odds of respiratory
illness could plausibly be the result of breastfeeding
mothers’ hyper-vigilance in regards to noticing and/or
reporting upper respiratory symptoms. A causal rela-
tionship is not outside the realm of possibility, however.
The breastfeeding relationship places infants and mothers
in very close proximity on a very regular basis, perhaps
facilitating transmission of respiratory viruses. Alterna-
tively, mothers of children with more frequent respiratory
symptoms may choose to breast feed for longer to impart
to their children perceived health benefits derived from
breast milk. It is also possible, as suggested above, that
respiratory illnesses in breastfeeding children tend to be
less severe than those in children who do not breast feed,
and therefore more frequently present as common cold,
instead of manifesting as febrile illness, or otitis media.
Significantly less existing literature addresses the rela-
tionship between breastfeeding as an infant and acute ill-
ness as a young child, after the cessation of breastfeeding.
Our study supports that exclusive breastfeeding for longer
duration is related to a decreased incidence of otitis media
once breastfeeding has stopped (i.e. beyond the age of 12
months) up to the age of 4 years. Longer duration of
exclusive breastfeeding protecting against future incidence
of otitis media has been suggested by other studies [25–
27], though none followed this trend as far as this study
did (up to 4 years of life). This is, therefore, an important
finding, as protective effects of breastfeeding in relation to
otitis media beyond the age of 2 years have been previ-
ously poorly supported and little studied [36]. This study
showed no relationship between the duration of exclu-
sive breastfeeding and future incidence of other types of re-
spiratory infections, or gastrointestinal infections, thus
failing to replicate previously published findings that longer
duration of exclusive breastfeeding protects against future
episodes of diarrhea [31], or future respiratory infections
outside of otitis media [26, 27, 31, 32].
Although a thorough exploration of the mechanisms
behind the health benefits of breastfeeding lies outside
the scope of this paper, other publications have exam-
ined this topic in detail. Breast milk has many properties
that may be protective against acute illness, including
secretory IgA against microbes to which the mother has
been exposed; antibacterial and antiviral agents like
lactoferrin, lysozyme and certain fatty acids; numerous
leukocytes; and oligosaccharides, which act as analogues
of microbial epithelial receptors, and therefore decoys
for potential pathogens [37–40]. The thymus of breast-
fed infants has been found to be larger than that of non-
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breastfed infants, and this has corresponded to increased
expression of T cells [40–42]. Breastfed infants have also
been found to have a larger number of healthy bacteria
(most notably Bifidocacteria and Lactobacilli) in their
gut microbiome, which in turn may have implications
for producing further antimicrobial compounds, redu-
cing intestinal permeability, competing with harmful
bacteria for nutrients and binding sites, and maturing
and stimulating local and systemic immune responses
[39, 43, 44]. It has been noted, however, that adding
even small amounts of formula to a predominately
breastmilk diet, or introducing solid foods, shifts the
microbiome of infants toward that of a formula-fed
infant, which may help to explain the greater protective
effects seen with exclusive breastfeeding when compared
to non-exclusive breastfeeding, demonstrated both by
this study and others [45, 46].
The strength of this study has been the relatively large
number of children that were followed prospectively and
regularly at three different sites within two different
continents, allowing for a recording of infections from
diverse populations under a common data collection
protocol. This limited somewhat the possibility of recall
bias and allowed us to examine the consistency of the as-
sociations across different populations. While the report-
ing of infections varied by continent [35], the association
of breastfeeding with febrile respiratory infections, com-
mon cold, otitis media, and gastroenteritis were similar
across continents. However, the protective influence of
breastfeeding at 3months for both ear infections and fe-
brile respiratory infections between 3 to 6 years of age was
seen only if the child was a girl and the 6month visit was
between December and February. This was not surprising,
as incidence of respiratory infections is highest in the fall
and winter [35] and young boys tend to have more infec-
tions than girls [47].
Despite the strengths of our study, there were also lim-
itations. Parental reporting of infections may still be
prone to misclassification as only symptomatic infections
were captured, and there was some difficulty differentiat-
ing between ICD10 codes of acute vs chronic infections.
Also, there is likely to be some selection bias as the
study excluded those participating families that were not
as compliant with the TEDDY protocol. As we have
reported in a prior publication, poor compliance or early
loss to follow-up were related to a higher proportion of
single, younger mothers, and mothers with fewer working
hours during pregnancy [48]. The influence of breastfeed-
ing on parental reported infections may differ among this
group of young families.
Conclusions
In summary, this study highlights and clarifies several
health-related benefits of breastfeeding, both while the
child is being breastfed and (to a lesser degree) in the
time period following breastfeeding cessation. Breast-
feeding is demonstrated to be beneficial in infancy and
early childhood in regards to certain respiratory and
gastrointestinal illnesses, with reduced incidence of otitis
media spanning from infancy even up to the age of 4
years for some breastfed children. These results should
be weighed by families in the context of their own abil-
ities and desires when it comes to breastfeeding, helping
to inform their decision-making process.
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